SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is currently a focal point for investors, driven by heavy institutional buying from firms like Blackrock and JPMorgan, combined with speculation over a potential short squeeze given its high short interest. Community sentiment remains deeply polarized between those betting on a turnaround under founder Tom Siebel's leadership and skeptics who are concerned about the company's historical revenue performance and market position relative to other AI software peers.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following the release of pivotal Phase 3 trial data for its pancreatic cancer candidate, daraxonrasib, which significantly improved overall survival compared to standard chemotherapy. Investors and clinicians are actively discussing the transformative clinical outcomes, which have sparked heightened acquisition speculation and multiple analyst price target increases as the company advances its regulatory filings.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is currently trending as investors debate the impact of broader institutional outflows and market volatility on Bitcoin, with community discussions heavily focused on whether recent price fluctuations represent a durable bottom or a precursor to further correction. Many participants are closely monitoring options flow and whale activity for signals on the asset's next structural move amidst a challenging macroeconomic environment.

SharonAI Holdings, Inc. operates as a holding company that develops and delivers GPU cloud computing and AI solutions. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is currently experiencing intense attention and high volatility driven by a massive multi-year infrastructure contract and strategic positioning from prominent institutional investors like Leopold Aschenbrenner's Situational Awareness. The community is actively debating the stock's potential for a major short squeeze due to its tight float, with many focusing on its role as a niche 'NeoCloud' provider amid broader AI hardware demand.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) remains a focal point for investors as central banks aggressively expand their gold reserves to hedge against geopolitical fragmentation and sustained inflationary pressures. The community is actively debating the sector's long-term outlook, weighing the potential for a monetary reset and fiscal stimulus against short-term volatility driven by rate hike speculation and shifting dollar dynamics.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund (XLF) is currently trending as investors debate the potential for a rotational shift into financial stocks, driven by bullish technical breakouts and institutional accumulation. While some market participants are monitoring banking stability and credit sector risks, the community remains divided between those capitalizing on the sector's relative strength and others warning of a broader economic cooling period.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark Inc. is trending as investors react to a combination of broader Bitcoin price volatility and intense speculation surrounding potential data center or AI partnership rumors. Community discussion is sharply divided between those accumulating shares on dips in anticipation of a transformative hyperscaler deal and skeptical voices concerned about executive compensation, high short interest, and the stock's continued correlation with crypto market movements.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is currently trending as a focal point for fintech investors, with strong sentiment driven by its resilient recurring loan revenue and the expansion of its partnership with Google's AI-driven platforms. The community is actively debating the stock's long-term valuation versus cyclical credit risks, with many traders closely monitoring its price action for signs of a major breakout.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing renewed investor interest and upward price momentum driven by strong institutional backing, consistent GAAP profitability, and a high-volume short interest that has led to speculation about a potential short squeeze. The community is actively discussing the stock's significant undervaluation relative to its growth prospects, while monitoring institutional buying and positive analyst sentiment as key catalysts for a potential breakout.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending due to strong institutional accumulation and positive analyst revisions, with market participants closely watching its role as critical infrastructure for scaling enterprise AI workloads. The community is actively debating the stock's growth trajectory ahead of its upcoming earnings report, focusing on how its observability platform benefits from the broader shift toward agentic AI deployment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last?

Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) PR Newswire NEW YORK, May 26, 2026 NEW YORK, May 26, 2026...

Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Goldman Sachs 47th Annual...

Orthofix Medical (NASDAQ:OFIX) Announces Quarterly Earnings Results, Beats Estimates By $0.16 EPS

Orthofix Medical (NASDAQ:OFIX - Get Free Report) issued its quarterly earnings data on Tuesday. The medical device company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.68) by $0.16. The firm had revenue of $196.71 million for the quarter, compared to...

Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE Innovation at POSNA 2026 Annual Meeting

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small...

Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights PR Newswire NEW YORK, May 5, 2026 Shareholders should contact the firm immediately as...

Orthofix Medical Q1 Earnings Call Highlights

Orthofix Medical (NASDAQ:OFIX) reported first-quarter 2026 results that management said reflect steadier execution, improving stability, and the early benefits of actions taken to reset its Spine...

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company...

Wall Street Zen Downgrades Orthofix Medical (NASDAQ:OFIX) to Hold

Wall Street Zen cut shares of Orthofix Medical from a "buy" rating to a "hold" rating in a research report on Saturday...

Orthofix Medical, Inc. develops and markets medical devices and biologic solutions for spine and orthopedic applications. The company operates through two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers two primary product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Bone Growth Therapies includes noninvasive stimulation devices used in spinal fusion and fracture-healing applications. Spinal Implants, Biologics, and Enabling Technologies includes a broad portfolio of spine fixation and motion-preservation products, biologic solutions, and image-guided surgical technologies used in spine procedures. The Global Limb Reconstruction segment provides products and solutions for limb reconstruction, deformity correction, fracture management, and other orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Orthofix Medical Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

OFIXOrthofix Medical Inc

Fundamentals

Latest OFIX News